About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in San Antonio | 90 Studies

Clinical Trials Colorectal CancerSan Antonio

Colorectal Cancer Clinical Trials in San Antonio

Find 90 clinical trials for colorectal cancer near San Antonio, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-90 of 90 trials

Active not recruitingA Study to Investigate APL-5125 in Adults With Advanced Solid TumorsThis is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors…NCT06399757·Duarte, California and 8 others CompletedCetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerThe purpose of this study is to compare the rates of Progression-Free Survival (PFS) at 12 months for patients treated with Bev-FOLFOX versus patients treated with FOLF-CB for…NCT00252564·Birmingham, Alabama and 81 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownCAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge StrategyThis is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated…NCT05291156·Ancona and 23 others

Active not recruitingA Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal CancerThis is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive…NCT04486378·Greenbrae, California and 84 others

CompletedFR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as FR901228, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00077337·Mobile, Alabama and 87 others

RecruitingA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic CancerThis is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer.NCT07227168·San Diego, California and 8 others

CompletedS1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerThis randomized phase II trial studies how well irinotecan hydrochloride and cetuximab with or without vemurafenib works in treating patients with colorectal cancer that has…NCT02164916·Anchorage, Alaska and 762 others

CompletedStudy to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal CancerThe main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab.NCT05954871·Nashville, Tennessee and 5 others

RecruitingA Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsThis clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors.NCT04657068·Birmingham, Alabama and 81 others

CompletedEpidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant ChemotherapyThis is a multi-site epidemiological study designed to monitor circulating tumor DNA (ctDNA) status in participants with Stage II (high risk)/III colorectal cancer (CRC) following…NCT04813627·California City, California and 73 others

PreviousPage 5 of 5

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma